ft.com
>
Companies
>
Health
News
Quotes
News
Quotes
Search
Advanced search
Sign in
Site tour
Register
Subscribe
Welcome
Subscribe
Your account
Site tour
Sign out
Username
Password
Forgot password?
Remember me on this computer
Sign in
Home
Video
Interactive
Blogs
Alphaville
beyondbrics
Portfolio
Special Reports
In depth
Today’s Newspaper
UK
Business
Economy
UK Companies
Politics & Policy
UK Small Companies
London 2012 Olympics
World
Africa
Asia-Pacific
Asia-Pacific
Afghanistan
China
India
Japan
North Korea
Pakistan
Europe
Europe
Brussels
Latin America & Caribbean
Latin America & Caribbean
Business
Economy
Finance
Politics & Policy
Regulation
Society
Middle East & North Africa
Middle East & North Africa
Economy
Finance
Politics & Society
Iran
Iraq
Arab-Israel conflict
UK
UK
Business
Economy
UK Companies
Politics & Policy
UK Small Companies
US & Canada
US & Canada
Economy
Politics & Policy
Society
Canada
The World blog
Companies
Energy
Energy
Mining
Oil & Gas
Utilities
Financials
Financials
Banks
Insurance
Property
Financial Services
Health
Health
Health Care
Pharmaceuticals
Industrials
Industrials
Aerospace & Defence
Automobiles
Basic Resources
Chemicals
Construction
Industrial Goods
Luxury 360
Media
Retail & Consumer
Retail & Consumer
Food & Beverage
Personal & Household Goods
Retail
Travel & Leisure
Tech
Tech
Science
Telecoms
Transport
Transport
Airlines
Shipping
Rail
By Region
By Region
US Companies
UK Companies
European Companies
Americas Companies
Asia-Pacific Companies
African Companies
Middle Eastern Companies
UK Small Companies
Tools
Tools
Portfolio
FT clippings
Alerts hub
Email briefings
MBA rankings
FT Lexicon
Mobile
Currency converter
ePaper
FT press cuttings
Privilege Club
Social Media hub
Economic calendar
Companies A-Z
FT30
FT 500
Companies Week Ahead
Companies Week in Review
Markets
Alphaville
FTfm
FTfm
Regulation
ETFs
Investment Strategy
Pensions
People
Opinion
Video
Markets Data
Markets Data
Bonds & Rates
Commodities
Funds
Director Deals
ETFs
Companies
Currencies
Investor Relations
Equity Indices
Interactive Charting
Data Archive
Portfolio
Economic Calendar
Trading Room
Trading Room
Clearing & Settlement
Developing Markets & Asia
Markets Regulation
Trading Technology
Quick View
Carbon Markets
Exchanges Consolidation
Equities
Equities
US
UK
Europe
Asia-Pacific
Currencies
Capital Mkts
Commodities
Emerging Mkts / beyondbrics
Global Economy
Economic Calendar
Money Supply
Americas
China
EU
India
Middle East
UK
US
Lex
About Lex
Best of Lex
Lex on Mobile
Lex by Email
Lex Video
Lexicon
Subscribe to Lex
Comment
Columnists
Columnists
Samuel Brittan
Christopher Caldwell
John Gapper
Brian Groom
John Kay
James Kynge
Edward Luce
Jurek Martin
Wolfgang Munchau
David Pilling
Ingram Pinn
Robert Pozen
Gideon Rachman
Robert Shrimsley
Gary Silverman
Philip Stephens
Gillian Tett
Martin Wolf
Analysis
Opinion
The A-List
Editorial
Blogs
Blogs
beyondbrics
Brussels Blog
Business Blog
Economists’ Forum
FT Alphaville
FT Tech hub
Gavyn Davies
Martin Wolf’s Exchange
Material World
MBA Blog
Money Supply
The World
Westminster Blog
Letters
Corrections
Obituaries
Management
Business Education
Business Education
All Rankings
MBA
Masters in Management
EMBA
Business School News
Features of the Week
Women at Business School
Entrepreneurship
Business Books
Business Travel
Recruitment
The Connected Business
Women at the Top
Personal Finance
Property & Mortgages
Investments
Investments
Trading Ideas
Pensions
Tax
Banking & Savings
Insurance
Money Matters
Money Matters
Deals
Top Tips
Advice & Comment
Advice & Comment
Adventurous Investor
Merryn Somerset Webb
My First Million
My Portfolio
Serious Money
Traders Diary
Wealth Questions
Calculators
Life & Arts
Arts
Arts
Collecting
Design & Architecture
Film & Television
Music
Theatre & Dance
Visual Arts
FT Magazine
Food & Drink
House & Home
Style
Books
Books
Essay
Fiction
Non-Fiction
Pursuits
Pursuits
Crossword
Sudoku
Travel
Travel
UK
North America
Europe
Asia & Australia
Africa
Americas
Luxury
Adventures
Winter Sports
Family
City Breaks
How To Spend It
Highlights
beyondbrics
Accountancy column
Luxury 360
FT Trading Room
Lombard
Business blog
Tech hub
From
WORLD
3:00pm
Athens struggles to rein in medical excess
Sector blighted by overspending on drugs and fakellaki bribery system
Greek parliament debates austerity bill
Lex
Greece / eurozone
In depth
Greek debt crisis
Comment
Let Greece stand on its own feet
Feb 10, 2012
US mental guidelines attacked
Move said to help drug companies
House of Lords votes against NHS bill
Doctors call for withdrawal of health bill
From
UK
Feb 10, 2012
Clegg fury at Tory moves to kill health bill
Lib Dem leader fears ministers’ lobbying could destabilise coalition
Tories tell Cameron to ditch health bill
PHARMACEUTICALS
Feb 10, 2012
Vernalis secures backing for US drugs deal
Lex
US pharma
Big pharma tipped as tonic for investors
Feb 9, 2012
Doughty Hanson buys Spanish hospital chain
UK private equity group pays €355m for USP
Obituary
City financier Nigel Doughty found dead
Banks’ asset selling hints at better conditions
PHARMACEUTICALS
Feb 9, 2012
ADHD drugs prove beneficial to Shire
UK drugs group reports 23% increase in revenues to $4.3bn
Lex
Shire
Shire buys Advanced BioHealing for $750m
PHARMACEUTICALS
Feb 8, 2012
Sanofi to receive $270m payment from Apotex
Settlement of long legal dispute over blockbuster drug Plavix
Lex
GlaxoSmithKline
Pharma seeks to ease pain of euro crisis
From
UK
Feb 8, 2012
Regulator hires medical devices supervisor
Appointment raises questions why post was left vacant
Call for UK register of implants
Private company to run NHS general hospital for first time
HEALTH CARE
Feb 8, 2012
Four Seasons races to refinance £780m in debt
UK care-home group seeks to raise £230m
Four Seasons in debt refinancing talks
Four Seasons takes on 54 homes
Feb 7, 2012
Illumina rebuffs Roche again
Diagnostics group calls hostile offer ‘grossly inadequate’
Roche steps up Illumina bid as sales hold up
Lex
Roche/Illumina
From
UK
Feb 7, 2012
Lansley under fire over NHS reforms
Tories fear bill could damage election chances
PHARMACEUTICALS
Feb 7, 2012
Eisai to focus on East Asia
Japanese drugmaker signals confidence in region
From
LEX
Feb 7, 2012
GlaxoSmithKline: word to the wise
Investors should watch the underlying numbers and the headline ones too
From
UK
Feb 7, 2012
Call for UK register of implants
Top officials’ plea adds to pressure for regulatory overhaul
From
WORLD
Feb 7, 2012
ANC report rejects nationalisation of mines
Analysis proposes higher taxes for S Africa sector
PHARMACEUTICALS
Feb 7, 2012
GSK empties accounts to limit euro exposure
‘Daily sweep’ of cash in fragile countries
From
WORLD
Feb 7, 2012
Hong Kong rages at wave of pregnant Chinese
Anger grows over access to hospital care and schools
From
WORLD
Feb 6, 2012
Hamas and Fatah to form unity government
Abbas to head administration of rival Palestinian factions
From
LEX
Feb 6, 2012
HCA: health warning
Those who want a cheap way to play a recovery should be careful
From
UK
Feb 5, 2012
Life after the NHS finds mutual ACE thriving
Enterprise spirit and roster of new contracts boosts government’s plan
Multimedia
Editorial
Dropping the UK’s National Health Service reform bill and pursuing change without legislation looks on balance the better bet
Lex
As GSK further expands abroad, investors should watch not only the underlying numbers, but the headline ones too
LEX
Despite the hospital chain’s strong cash flows, HCA’s shareholders should be careful of getting whipsawed
More stories
Energy
Small-caps: Solo Oil and Aminex rebound
Mining’s bruiser-in-chief builds a behemoth
Fidelity calls for revised Glencore deal
Bumi’s foundations undermined by spat
Financials
Lord Davies warns over attacks on bonuses
Salvation Army appoints property manager
IMF deal critical for Egypt, say economists
Green light for Nomura mainland move
Industrials
Dyson aims to expand as sales top £1bn
Midlands manufacturers forge Olympic torch
Cevian builds stake in Cookson
Troubleshooter Louis Gallois bows out
Telecoms
C&WC outlook clouded by Panama problems
Bango jumps 40% on Facebook deal
Alcatel-Lucent dispels free cash flow fears
América Móvil profits fall on higher debt costs
Technology
Acer seeks makeover in Europe
Activision Blizzard: lurking dangers
Valentine's boost for online dating sites
Iranians fear censorship over blocked internet
Markets
Access to junk bond market revives LBOs
Greek woes unsettle stocks and euro
The bulls return, but for how long?
S&P downgrades ratings of 34 Italian banks
Offers
EXEC-APPOINTMENTS.COM
Global executive jobs
Register today for free job alerts
JOIN THE BUSINESS ELITE
More people at the top read the FT*
*FT has grown in every major readership survey in 2010
FT SUBSCRIPTION
Subscribe today!
Save and get FREE delivery
Companies videos
You need JavaScript active on your browser in order see this video.
Editor's Choice
online dating
A Valentine’s business boost as lovers log on
FT magazine
Suleiman Kerimov, the secret oligarch
In depth
Consumer Electronics Show 2012
Detroit Auto Show 2012
Bank bonuses
Initial public offerings
Phone-hacking scandal
More in depth
Highlights
Most popular in Companies
Full text: Memo to Sun staff
S&P downgrades ratings of 34 Italian banks
MF Global loss estimate revised upwards
Latest pact on internet piracy set to be derailed
Peacocks staff plead for chain’s survival
exec-appointments.com
Enter job search
Search
Independent Members
The Global Fund
HEAD OF STRATEGIC PLANNING
The University of East London
Business Development Directors
NBCUniversal
Chief Operating Officer
Bovill
Register for free to receive the latest executive jobs by email
Multimedia
Video
Blogs
Podcasts
Interactive graphics
Audio slideshows
Picture slideshows
Tools
Portfolio
FT Lexicon
FT clippings
Currency converter
MBA rankings
Today's newspaper
FT press cuttings
FT ePaper
Economic calendar
Updates
Alerts Hub
Daily briefings
FT on your mobile
Share prices on your phone
Twitter feeds
RSS feeds
Quick links
Mergermarket
How to spend it
SchemeXpert.com
Social Media hub
The Banker
fDi Intelligence
Professional Wealth Management
This is Africa
Investors Chronicle
MandateWire
FTChinese.com
Services
Subscriptions
Corporate subscriptions
Syndication
Privilege Club
Conferences
Annual reports
Executive job search
Non-Executive Directors' Club
Businesses for sale
Contracts & tenders
Analyst research
Company announcements
GlaxoSmithKline: word to the wise
Investors should watch the underlying numbers and the headline ones too